Riskpilot← Back to searchSign inGet full accessFrölunda tandvård AB
ABActiveOrg 5592576077Kontrabasgatan 5 DDental practice care activities · NACE 8623Est. 20200 employees
Revenue 2024
SEK 550K
-7% vs 2023
EBITDA margin
-4.5%
-140% vs 2023
Equity ratio
79.4%
Financial strength
Net profit 2024
SEK -2K
-105% vs 2023
| Revenue | SEK 550K | -7% |
| EBITDA | SEK -25K | -140% |
| Net profit | SEK -2K | -105% |
| Total assets | SEK 170K | -33% |
| Equity | SEK 135K | -1% |
| Employees | 0 | — |
Legal name
Frölunda tandvård AB
Org number
5592576077
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
29 maj 2020
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Tandläkarverksamhet.
Address
Kontrabasgatan 5 D
Email
frolundatandvard@yahoo.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 270 | 1 230 | 900 | 590 | 550 |
| Staff expenses | — | — | −4 | −3 | −0 |
| EBITDA | −3 | 6 | 116 | 62 | −25 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −3 | 6 | 116 | 62 | −25 |
| Net financials | — | — | — | 0 | −2 |
| Profit before tax | −3 | 5 | 91 | 47 | −2 |
| Tax | −0 | −0 | −19 | −10 | −0 |
| Net profit | −3 | 5 | 72 | 37 | −2 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 419 | 393 | 249 | 253 | 170 |
| Equity | 22 | 28 | 100 | 137 | 135 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 397 | 365 | 124 | 76 | 20 |
| Total debt | 397 | 365 | 124 | 76 | 20 |
EBITDA margin
-4.5%
This company
15.8%
Market median
-128% vs market
20202024
Equity ratio
79.4%
This company
38.2%
Market median
+108% vs market
20202024
Return on equity
-1.4%
This company
18.4%
Market median
-108% vs market
20202024
Net profit margin
-0.3%
This company
8.1%
Market median
-104% vs market
20202024
Asset turnover
3.23×
This company
1.12×
Market median
+188% vs market
20202024
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-05-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HS Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Frölunda tandvård AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hesam Sowlati Manesh | Chief Executive Officer | 0 companies |
| Maha Hosna Sowlatimanesh | Deputy Board Member | 0 companies |
| Behrooz Ghahreman Zadeh | Chairman | 0 companies |